Ledger.Open graph →
SEC Form D · filed February 19, 2016

ReSet Therapeutics, Inc

Offering
$47.2M
Sold
$29.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Shuichi B. Kurosaki · South San Francisco, CAExecFrederick B. Craves · San Francisco, CADirectorRoss Bersot · San Francisco, CAExec · DirectorPeter B. Schultz · South San Francisco, CADirectorSteve B. Kay · South San Francisco, CADirectorHoyoung B. Huh · South San Francisco, CADirectorPaul B. Humphries · South San Francisco, CAExecMichael P. Hite · Seattle, WAExecGary Langendoen · Pasadena, CADirectorJason A. Gilbert · Dallas, TXExecEric I. Hickman · Denver, CODirectorBen H. Weinberg · Minneapolis, MNExec · DirectorJohn D. Hoekman · Seattle, WAExec · DirectorParker A. Hallam · Dallas, TXDirectorStewart D. Parker · Seattle, WADirectorQuentin Blackford · Carlsbad, CAExec · DirectorMatthew Arnold · Lafayette, CODirectorAshoke D. Goswami · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗